Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05963984
Title A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants (SUMIT-BC)
Acronym SUMIT-BC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Carrick Therapeutics Limited
Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.